In addition to regulating the production of ceramides by FXR, BAs can also regulate FXR by the production of fibroblast growth factor 15 (FGF15, FGF19 in humans) and TGR5, thus regulating metabolic disorders [69]. Here, GPBAR1 is linked to metabolic disease.